US Artificial Tear Market Reaches $577.5 Million in 2025 with 5.1% CAGR

US artificial tear market was valued at $577.5 million in 2025 and is projected to reach $944.1 million by 2035, growing at a CAGR of 5.1% during the forecast period (2026–2035). Artificial tears are widely used to manage dry eye disease (DED) and ocular surface disorders by lubricating the eyes, stabilizing the tear film, and relieving irritation caused by environmental stress, prolonged screen exposure, contact lens use, aging, and post-surgical conditions. The market includes preservative-free and preserved formulations, gels, ointments, lipid-based drops, and advanced polymer-based solutions tailored for mild to severe dry eye. This market is experiencing steady growth across the United States, driven by the high prevalence of dry eye disease, increasing screen time and digital eye strain, an aging population, and growing awareness of preventive eye care. Additional momentum comes from the shift toward preservative-free formulations, rising post-LASIK and cataract surgery volumes, and strong over-the-counter (OTC) availability through retail pharmacies and e-commerce channels. Continuous product innovation, improved formulations mimicking natural tears, and physician preference for safer long-term therapies are collectively fueling sustained market expansion.

Browse the full report description of “US Artificial Tears Market Size, Share & Trends Analysis Report by Type (Cellulose-Derived Tears, Glycerin-Derived Tears, Oil-Based Emulsion Tears, and Polyethylene Glycol- & Propylene Glycol-Based Tears), By Delivery Method (Eyedrops and Ointments/Gel), By Application (Dry Type Treatment, Contact Lens Moisture, and Digital Eye Strain) and By End-User (Retail Pharmacies (OTC), Online Pharmacies, Hospitals & Ophthalmic Clinics, and Other End User) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/us-artificial-tears-market

According to PMC, Sjögren’s Canada, and the National Eye Institute (NEI), the prevalence of dry eye disease (DED) and related ocular symptoms in North America is substantial, driving increased demand for artificial tears across clinics, pharmacies, and consumer channels, especially as aging, screen time, and environmental factors contribute to eye surface irritation.

Key Innovators Driving US Artificial Tear Transformation

The key players in the US artificial tear market include Abbott Laboratories, AbbVie Inc., Alcon Inc., Bausch + Lomb Corporation, Johnson & Johnson, among others. These players are advancing innovation through improved tear-film-mimicking technologies, preservative-free delivery systems, and targeted formulations for different dry eye subtypes.

• In March 2025, Bausch + Lomb launched a new line of preservative-free artificial tears in the U.S., featuring advanced lipid-based formulations tailored for patients with moderate to severe dry eye, reinforcing its leadership in ocular-surface care.
• In January 2025, Hubble Contacts partnered with major U.S. pharmacy chains to broaden distribution of its over-the-counter artificial tear solutions, improving accessibility for digital-device users and individuals with mild to moderate dry eye symptoms.
• In 2025, Alcon expanded its US dry eye portfolio with next-generation preservative-free artificial tear formulations, designed to provide longer-lasting lubrication and enhanced patient comfort, reinforcing its leadership in the US ophthalmic OTC segment.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • Delivery Method
  • By Application
  • By End-User
• Competitive Landscape - Abbott Laboratories, AbbVie Inc., Alcon Inc., Bausch + Lomb Corporation, Johnson & Johnson, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

US Artificial Tear Market Report Segment

By Type

• Cellulose-Derived Tears
• Glycerin-Derived Tears
• Oil-Based Emulsion Tears
• Polyethylene Glycol- & Propylene Glycol-Based Tears

By Delivery Method

• Eyedrops
• Ointments/Gel

By Application

• Dry Type Treatment
• Contact Lens Moisture
• Digital Eye Strain

By End-User

• Retail Pharmacies (OTC)
• Online Pharmacies
• Hospitals & Ophthalmic Clinics
• Other End User

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-artificial-tears-market